Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like <B>Lesaffre</B> Invests In Intralytix, A U.S. Biotechnology Company July 24, 2017 FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros February 15, 2018 Internationally Renowned City of Hope Scientist Ph.D., Named Chair In Diabetes & Drug Discovery February 9, 2017
Internationally Renowned City of Hope Scientist Ph.D., Named Chair In Diabetes & Drug Discovery February 9, 2017
